Skip to content
WeighLab

Next Vial vs Curex

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Next Vial

Provider comparison

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Semaglutide / month
$199/moMonth-to-month, all doses, compounded
Tirzepatide / month
$249/moMonth-to-month, all doses, compounded
Index 76/100 · Grade CChecked October 2026

Curex

Provider comparison

People who want a low-cost first month and an oral option nationwide, and who will either pay monthly or prepay a year for the lower rate.

Semaglutide / month
$299/moMonth-to-month (first month $49; $199/mo prepaid for a year)
Tirzepatide / month
$399/moMonth-to-month (first month $149; $299/mo prepaid for a year)
Index 75/100 · Grade C

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Next Vial has the higher Cost-Efficiency Index: 76/100 versus 75/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Next Vial
49 states
Curex
All 50 states (California: oral tablet only, no injectable)

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Next Vial

Curex

Semaglutide / month
Next Vial: $199/moMonth-to-month, all doses, compounded
Curex: $299/moMonth-to-month (first month $49; $199/mo prepaid for a year)
Tirzepatide / month
Next Vial: $249/moMonth-to-month, all doses, compounded
Curex: $399/moMonth-to-month (first month $149; $299/mo prepaid for a year)
Semaglutide / year (modeled)
Next Vial: $2,388
Curex: $3,588
Tirzepatide / year (modeled)
Next Vial: $2,988
Curex: $4,788
State availability
Next Vial: 49 states
Curex: All 50 states (California: oral tablet only, no injectable)
Oral / sublingual option listed
Next Vial: Not listed
Curex: Yes
Brand-name access listed
Next Vial: Not confirmed
Curex: Not confirmed
Provider facts checked
Next Vial: October 2026
Curex: See full review

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Next Vial

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Reasons to consider it

  • Names Manifest Pharmacy as a dispensing partner
  • Displays a LegitScript verification link
  • Publishes a 49-state coverage list, excluding Alaska

What to weigh up

  • The lowest advertised monthly equivalents require paying for a longer supply up front
  • The page headline differs from the actual plan selector, so use the selected plan total
  • No individual medical director is named

Curex

People who want a low-cost first month and an oral option nationwide, and who will either pay monthly or prepay a year for the lower rate.

Reasons to consider it

  • Discounted first month well below the ongoing rate — $49 for semaglutide, $149 for tirzepatide
  • Publishes a plain price table: monthly rates, plus a prepaid-year option at $199 (semaglutide) or $299 (tirzepatide) a month
  • Nationwide enrollment (all 50 states) plus an oral/sublingual route as an alternative to injections

What to weigh up

  • The 'From $199/mo' headline is the prepaid-year rate ($2,388 up front); paid monthly, semaglutide is $299 and tirzepatide $399
  • California residents cannot get the injectable route at all — oral tablets only, despite the 'all 50 states' enrollment claim
  • Named clinical leadership is disclosed in the context of Curex's original allergy-clinic business, not confirmed as GLP-1-specific prescribers

Regulatory note: the FDA issued a warning letter to Curex in September 2025. We still list and link to Curex; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Next VialCurex
Normalized Cost/Month
Next Vial:
68/100
Curex:
52/100
Price Transparency
Next Vial:
97/100
Curex:
75/100
Nationwide Access
Next Vial:
78/100
Curex:
90/100
Formulation Options
Next Vial:
66/100
Curex:
84/100
Clinical Oversight
Next Vial:
82/100
Curex:
80/100
Contract Flexibility
Next Vial:
55/100
Curex:
80/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.